Literature DB >> 24184696

Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system.

Keith A Sharkey1, Nissar A Darmani2, Linda A Parker3.   

Abstract

Nausea and vomiting (emesis) are important elements in defensive or protective responses that animals use to avoid ingestion or digestion of potentially harmful substances. However, these neurally-mediated responses are at times manifested as symptoms of disease and they are frequently observed as side-effects of a variety of medications, notably those used to treat cancer. Cannabis has long been known to limit or prevent nausea and vomiting from a variety of causes. This has led to extensive investigations that have revealed an important role for cannabinoids and their receptors in the regulation of nausea and emesis. With the discovery of the endocannabinoid system, novel ways to regulate both nausea and vomiting have been discovered that involve the production of endogenous cannabinoids acting centrally. Here we review recent progress in understanding the regulation of nausea and vomiting by cannabinoids and the endocannabinoid system, and we discuss the potential to utilize the endocannabinoid system in the treatment of these frequently debilitating conditions.
© 2013 Published by Elsevier B.V.

Entities:  

Keywords:  Brainstem; CB(1) receptor; CB(2) receptor; Cannabis; Emesis; Insular cortex; Serotonin

Mesh:

Substances:

Year:  2013        PMID: 24184696      PMCID: PMC3883513          DOI: 10.1016/j.ejphar.2013.09.068

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  191 in total

Review 1.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

2.  Exposure to a lithium-paired context elicits gaping in rats: A model of anticipatory nausea.

Authors:  Cheryl L Limebeer; Geoffrey Hall; Linda A Parker
Journal:  Physiol Behav       Date:  2006-06-05

Review 3.  The endocannabinoid system and the brain.

Authors:  Raphael Mechoulam; Linda A Parker
Journal:  Annu Rev Psychol       Date:  2012-07-12       Impact factor: 24.137

4.  Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.

Authors:  E M Rock; R L Kopstick; C L Limebeer; L A Parker
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

5.  Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus.

Authors:  E M Rock; D Bolognini; C L Limebeer; M G Cascio; S Anavi-Goffer; P J Fletcher; R Mechoulam; R G Pertwee; L A Parker
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

6.  Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis.

Authors:  M Pomeroy; J J Fennelly; M Towers
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes.

Authors:  M S Kipnes; P Hollander; K Fujioka; I Gantz; T Seck; N Erondu; Y Shentu; K Lu; S Suryawanshi; M Chou; A O Johnson-Levonas; S B Heymsfield; D Shapiro; K D Kaufman; J M Amatruda
Journal:  Diabetes Obes Metab       Date:  2010-06       Impact factor: 6.577

Review 8.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

9.  A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew).

Authors:  Magdalena Kwiatkowska; Linda A Parker; Page Burton; Raphael Mechoulam
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

10.  Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.

Authors:  S Frytak; C G Moertel; J R O'Fallon; J Rubin; E T Creagan; M J O'Connell; A J Schutt; N W Schwartau
Journal:  Ann Intern Med       Date:  1979-12       Impact factor: 25.391

View more
  58 in total

1.  Role of cannabinoidergic system on food intake in neonatal layer-type chicken.

Authors:  Abbas Alizadeh; Morteza Zendehdel; Vahab Babapour; Saeed Charkhkar; Shahin Hassanpour
Journal:  Vet Res Commun       Date:  2015-04-23       Impact factor: 2.459

2.  Medicinal use of cannabis in Europe: the fact that more countries legalize the medicinal use of cannabis should not become an argument for unfettered and uncontrolled use.

Authors:  Maurizio Bifulco; Simona Pisanti
Journal:  EMBO Rep       Date:  2015-01-09       Impact factor: 8.807

Review 3.  Novel Treatments for Cyclic Vomiting Syndrome: Beyond Ondansetron and Amitriptyline.

Authors:  Sanjay Bhandari; Thangam Venkatesan
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

Review 4.  Marijuana Use in Pregnancy and While Breastfeeding.

Authors:  Torri D Metz; Laura M Borgelt
Journal:  Obstet Gynecol       Date:  2018-11       Impact factor: 7.661

5.  Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation.

Authors:  Erin M Rock; Cheryl L Limebeer; Jordan M Ward; Arianne Cohen; Katherine Grove; Micah J Niphakis; Benjamin F Cravatt; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2015-08-23       Impact factor: 4.530

6.  Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.

Authors:  María Gómez-Cañas; Gemma Navarro; Paula Morales; Dow P Hurst; Francisco J Carrillo-Salinas; Laura Lagartera; Ruth Pazos; Pilar Goya; Patricia H Reggio; Carmen Guaza; Rafael Franco; Javier Fernández-Ruiz; Nadine Jagerovic
Journal:  J Med Chem       Date:  2016-07-06       Impact factor: 7.446

Review 7.  Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Authors:  Cecilia J Sorensen; Kristen DeSanto; Laura Borgelt; Kristina T Phillips; Andrew A Monte
Journal:  J Med Toxicol       Date:  2016-12-20

8.  Effect of combined doses of Δ(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping.

Authors:  Erin M Rock; Cheryl L Limebeer; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2015-09-18       Impact factor: 4.530

Review 9.  Cannabinoids and GI Disorders: Endogenous and Exogenous.

Authors:  Zachary Wilmer Reichenbach; Ron Schey
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

Review 10.  The Role of the Endocannabinoid System in the Brain-Gut Axis.

Authors:  Keith A Sharkey; John W Wiley
Journal:  Gastroenterology       Date:  2016-04-29       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.